What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Statistics
His primary areas of investigation include Attention deficit hyperactivity disorder, Psychiatry, Methylphenidate, Randomized controlled trial and Clinical psychology.
The various areas that Scott H. Kollins examines in his Attention deficit hyperactivity disorder study include Internal medicine, Logistic regression, Pediatrics and Lisdexamfetamine Dimesylate.
Scott H. Kollins usually deals with Internal medicine and limits it to topics linked to Endocrinology and Brain mapping.
Scott H. Kollins interconnects Drug, Irritability, Substance abuse and Stimulant in the investigation of issues within Methylphenidate.
His study in Randomized controlled trial is interdisciplinary in nature, drawing from both Clonidine, Anesthesia, Adverse effect and Rating scale.
In Clinical psychology, Scott H. Kollins works on issues like Research design, which are connected to Psychometrics, Clinical trial, Discontinuation and Parent training.
His most cited work include:
- Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications (449 citations)
- Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD. (332 citations)
- Temporal discounting: basic research and the analysis of socially important behavior. (304 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Attention deficit hyperactivity disorder, Psychiatry, Clinical psychology, Methylphenidate and Young adult.
His Attention deficit hyperactivity disorder study incorporates themes from Internal medicine, Adverse effect, Randomized controlled trial, Developmental psychology and Pediatrics.
His work in Psychiatry addresses subjects such as Lisdexamfetamine Dimesylate, which are connected to disciplines such as Lisdexamfetamine.
In general Clinical psychology, his work in Psychometrics is often linked to Kappa linking many areas of study.
As a part of the same scientific family, Scott H. Kollins mostly works in the field of Methylphenidate, focusing on Extended release and, on occasion, Methylphenidate Hydrochloride.
His Young adult research integrates issues from Longitudinal study, Obesity, Cognition and Retrospective cohort study.
He most often published in these fields:
- Attention deficit hyperactivity disorder (50.22%)
- Psychiatry (42.67%)
- Clinical psychology (27.56%)
What were the highlights of his more recent work (between 2018-2021)?
- Attention deficit hyperactivity disorder (50.22%)
- Clinical psychology (27.56%)
- Mental health (6.67%)
In recent papers he was focusing on the following fields of study:
Scott H. Kollins mostly deals with Attention deficit hyperactivity disorder, Clinical psychology, Mental health, Young adult and Physical therapy.
Scott H. Kollins studies Methylphenidate Hydrochloride, a branch of Attention deficit hyperactivity disorder.
His research on Clinical psychology focuses in particular on Methylphenidate.
His biological study deals with issues like Nicotine, which deal with fields such as Toxicant, Fixed dose and Abuse liability.
The Physical therapy study combines topics in areas such as Cognition, Test of Variables of Attention, Intervention, Tolerability and Randomized controlled trial.
He combines subjects such as Longitudinal study and Psychiatry with his study of Smoking initiation.
Between 2018 and 2021, his most popular works were:
- A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. (22 citations)
- A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. (22 citations)
- Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm. (17 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Statistics
Scott H. Kollins mainly focuses on Attention deficit hyperactivity disorder, Clinical psychology, Young adult, Tolerability and Physical therapy.
He has included themes like Cigarette smoking, Longitudinal study, Lisdexamfetamine Dimesylate, Pediatrics and Double blind in his Attention deficit hyperactivity disorder study.
His work on Methylphenidate as part of general Clinical psychology study is frequently linked to Evidence-based practice, bridging the gap between disciplines.
The study incorporates disciplines such as Test, Psychiatry, Smoking initiation and Trial registration in addition to Young adult.
His Tolerability research includes elements of Intervention, Randomized controlled trial and Cognition, Test of Variables of Attention.
His Physical therapy research incorporates elements of mHealth, Psychological intervention, Observational study and Electroencephalography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
